Comprehensive Study Guide for Leukemia Pathophysiology, Types, and Management

Fundamental Concepts of Leukocytosis and Leukemia

• Leukocytosis: This is explicitly defined as an increase in the number of leukocytes that are present in the systemic circulation.

• Leukocytes: Also known as white blood cells, these are the primary cells responsible for fighting infection within the body.

• Pathophysiology (Patho) of Leukocytosis: The condition is driven by the unregulated proliferation of leukocytes within the bone marrow. This massive increase in production creates a crowded environment that leaves little room for the production of normal blood cells.

• Leukemia: This is the clinical term for cancer of the white blood cells.

• Causes and Risk Factors for Leukemia:

  • Exposure to ionizing radiation.

  • Exposure to various chemicals.

  • Presence of certain genetic disorders.

  • Viral infections, which are known to increase the statistical chances of developing the disease.

Classification and Types of Leukemia

Leukemias are categorized based on the specific stem cell line involved and the speed of disease progression.

• Stem Cell Line Categorization:

  • Lymphoid: Involves lymphoid stem cells that are responsible for producing lymphocytes.

  • Myeloid: Refers to stem cells that produce nonlymphoid blood cells.

• Progression Categorization (Acute vs. Chronic):

  • Acute Leukemia: Signs and symptoms ($s/s$) can be abrupt. The cells involved are typically undifferentiated or "blasts." This form progresses rapidly; without aggressive treatment ($t/x$), death can occur within a timeframe of weeks to months.

  • Chronic Leukemia: Signs and symptoms evolve slowly over a period of months to years. In this form, the majority of the leukocytes produced are mature, leading to a much slower progression of the disease.

Acute Myeloid Leukemia (AML)

• Overview: AML is the most common form of leukemia and is the type where the most deaths occur. While it can affect any age group, the average age for diagnosis is $68$ years old.

• Risk Factors for AML:

  • Advanced age.

  • Male gender.

  • Exposure to chemicals such as pesticides.

  • A medical history ($h/x$) of past chemotherapy treatments.

  • Tobacco smoke inhalation.

  • Genetic disorders, specifically Down syndrome.

  • Pre-existing blood disorders.

• Clinical Manifestations ($s/s$):

  • Anemia.

  • Thrombocytopenia (low platelet count).

  • Neutropenia (low neutrophil count).

  • General impairment of neutrophils, basophils, and eosinophils.

  • Pain associated with an enlarged liver (hepatomegaly) or spleen (splenomegaly).

  • Hyperplasia of the gums.

  • Bone marrow pain resulting from the physical expansion of the marrow within the bone.

• Focus: Thrombocytopenia Symptoms and Labs:

  • If a patient exhibits symptoms of thrombocytopenia, one would expect signs of spontaneous bleeding and easy bruising.

  • Lab results will explicitly show a low platelet count.

  • Symptoms range from mild mucosal or skin bleeding to life-threatening internal hemorrhaging, depending on the severity of the decline in platelets.

• Treatment ($t/x$):

  • Chemotherapy.

  • Allogeneic stem cell transplant.

• Allogeneic Stem Cell Transplant: This is a specific type of transplant that replaces a patient's diseased or damaged bone marrow with healthy blood-forming stem cells provided by a donor.

• Major Complications: The primary complications for AML include bleeding and infection.

Chronic Myeloid Leukemia (CML)

• Overview: CML is a slow-growing blood cancer. The bone marrow produces an excess of abnormal white blood cells; while it primarily involves mature cells, some immature cells are also affected.

• Risk Factors for CML:

  • Advanced age.

  • Chemicals such as pesticides.

  • History of past chemotherapy treatments.

  • Tobacco smoke.

  • Exposure to high doses of radiation.

• Clinical Manifestations ($s/s$):

  • Fatigue.

  • Anemia.

  • Dyspnea (shortness of breath).

  • Weight loss.

• Treatment ($t/x$):

  • Tyrosine Kinase Inhibitors ($TKI$).

• Tyrosine Kinase Inhibitors ($TKI$) Mechanism of Action ($MOA$):

  • A primary example is Imatinib (Gleevec).

  • This medication works by blocking the specific signals that cause unregulated cell growth within the body.

Acute Lymphocytic Leukemia (ALL)

• Overview: ALL is an aggressive blood cancer that causes the bone marrow to produce an overabundance of immature white blood cells known as lymphoblasts.

• Risk Factors and Demographics:

  • It is most commonly found in children.

  • The average age for diagnosis is $15$ years old.

  • History of chemotherapy or radiation exposure.

  • Presence of certain genetic conditions.

• Diagnosis: ALL is typically identified during routine laboratory tests or a standard physical examination.

• Treatment ($t/x$):

  • Chemotherapy.

  • Corticosteroids.

Chronic Lymphocytic Leukemia (CLL)

• Overview: CLL is a slow-growing cancer affecting the lymphocytes. It is generally considered not curable and progresses very slowly. Many patients can live for years without requiring active treatment.

• Risk Factors and Demographics:

  • Typically occurs in older adults.

  • The average age of diagnosis is $71$ years old.

  • Family disposition/genetics.

  • Veterans of the Vietnam War who were exposed to Agent Orange (a herbicide).

• Clinical Manifestations ($s/s$):

  • Patients are typically asymptomatic.

• Diagnosis: CLL is usually diagnosed through routine laboratory work or physical exams. However, clinical signs may include an enlarged liver or spleen.

• Treatment ($t/x$):

  • Chemotherapy.

Nursing Interventions for All Leukemia Types

Clinical management for leukemia patients involves comprehensive care focusing on the following interventions:

• Managing leukocytosis.

• Improving nutritional intake.

• Easing pain and discomfort.

• Decreasing fatigue levels.

• Improving activity tolerance.

• Maintaining fluid and electrolyte ($f/e$) balance.

• Improving self-care capabilities.

• Managing anxiety and the process of grief.

• Encouraging spiritual well-being.

• Promoting and preparing for home care.